Evidence map›Paper›PMID 37575021›Full record

ArticleThe EMBO journal2023

Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease models.

Javier Rueda-Carrasco, Dimitra Sokolova, Sang-Eun Lee, Thomas Childs, Natália Jurčáková, Gerard Crowley, Sebastiaan De Schepper, Judy Z Ge, Joanne I Lachica, Christina E Toomey and 7 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Immune-mediated excitotoxicity in brain disorders.Nature reviews. Immunology · 2026
    Review
  4. Perisynaptic Astrocytic Processes as Communication Hubs and Early Sites of Dysfunction.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Metabolic Brain Disorders: Prodromes, Symptoms, and Syndromes.International journal of molecular sciences · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. How Do Amyloid Pathology and Aberrant Neuronal Activity Disrupt Plasticity and Memory in Alzheimer's Disease?The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2026
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Javier Rueda-Carrasco *UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.ORCID 0000-0002-9280-6612
Dimitra Sokolova *UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.
Sang-Eun Lee *UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.
Thomas ChildsUK Dementia Research Institute, Institute of Neurology, University College London, London, UK.ORCID 0000-0003-1048-8495
Natália JurčákováUK Dementia Research Institute, Institute of Neurology, University College London, London, UK.
Gerard CrowleyUK Dementia Research Institute, Institute of Neurology, University College London, London, UK.
Sebastiaan De SchepperUK Dementia Research Institute, Institute of Neurology, University College London, London, UK.
Judy Z GeUK Dementia Research Institute, Institute of Neurology, University College London, London, UK.
Joanne I LachicaThe Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
Christina E ToomeyThe Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0002-5146-3326
Oliver J FreemanNeuroscience BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.ORCID 0000-0003-4009-282X
John HardyUK Dementia Research Institute, Institute of Neurology, University College London, London, UK.ORCID 0000-0002-3122-0423
Samuel J BarnesUK Dementia Research Institute, Department of Brain Sciences, Imperial College London, London, UK.
Tammaryn LashleyThe Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0001-7389-0348
Beth StevensF.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.
Sunghoe ChangDepartment of Physiology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.
Soyon HongUK Dementia Research Institute, Institute of Neurology, University College London, London, UK.ORCID 0000-0002-5744-4871
UK Dementia Research Institute · GBNational Hospital for Neurology and Neurosurgery · GBAstraZeneca (United Kingdom) · GBSeoul National University · KRBroad Institute · US

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
NICHD NIH HHS P50 HD105351Wellcome TrustWellcome Trust 219906/Z/19/Z
6 · The paper itself

Abstract

Neuronal hyperactivity is a key feature of early stages of Alzheimer's disease (AD). Genetic studies in AD support that microglia act as potential cellular drivers of disease risk, but the molecular determinants of microglia-synapse engulfment associated with neuronal hyperactivity in AD are unclear. Here, using super-resolution microscopy, 3D-live imaging of co-cultures, and in vivo imaging of lipids in genetic models, we found that spines become hyperactive upon Aβ oligomer stimulation and externalize phosphatidylserine (ePtdSer), a canonical "eat-me" signal. These apoptotic-like spines are targeted by microglia for engulfment via TREM2 leading to amelioration of Aβ oligomer-induced synaptic hyperactivity. We also show the in vivo relevance of ePtdSer-TREM2 signaling in microglia-synapse engulfment in the hAPP NL-F knock-in mouse model of AD. Higher levels of apoptotic-like synapses in mice as well as humans that carry TREM2 loss-of-function variants were also observed. Our work supports that microglia remove hyperactive ePtdSer

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsDisease Models, AnimalHumansMembrane GlycoproteinsMiceMicrogliaReceptors, ImmunologicSynapsesAmyloid beta-PeptidesMembrane GlycoproteinsReceptors, ImmunologicTREM2 protein, humanAbeta oligomersAlzheimer's diseasemicrogliapruningsynapses

Identifiers

PMID37575021
PMCPMC10548173
OpenAlexW4385797886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.